Viral Detection Market - Global Outlook and Forecast 2021-2027

Viral Detection Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ973194 | No. of Pages: 90 | Category: Telecom and IT
Publisher: Market Monitor Global | Date of Publish: Oct-2021
This report contains market size and forecasts of Viral Detection in Global, including the following market information:
Global Viral Detection Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Viral Detection market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral Detection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Detection Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Viral Detection Market Segment Percentages, By Type, 2020 (%)
    Plaque Assays
    PCR
    ELISA
    Others

China Viral Detection Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Viral Detection Market Segment Percentages, By Application, 2020 (%)
    Blood & Blood Products
    Cellular & Gene Therapy Products
    Stem Cell Products
    Tissue & Tissue Products
    Vaccines and Therapeutics

Global Viral Detection Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Viral Detection Market Segment Percentages, By Region and Country, 2020 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Viral Detection Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Viral Detection Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
    Avance Biosciences Inc (US)
    BSL BIOSERVICE (Germany)
    Clean Cells (France)
    Charles River Laboratories International, Inc (US)
    Lonza Group (Switzerland)
    Merck KGaA (Germany)
    Sigma-Aldrich Corporation (US)
    SGS S.A. (Switzerland)
    Texcell, Inc. (France)
    WuXi PharmaTech (Cayman) Inc. (China)
1 Introduction to Research & Analysis Reports
    1.1 Viral Detection Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Viral Detection Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Viral Detection Overall Market Size
    2.1 Global Viral Detection Market Size: 2021 VS 2027
    2.2 Global Viral Detection Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Viral Detection Players in Global Market
    3.2 Top Global Viral Detection Companies Ranked by Revenue
    3.3 Global Viral Detection Revenue by Companies
    3.4 Top 3 and Top 5 Viral Detection Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Viral Detection Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Viral Detection Players in Global Market
        3.6.1 List of Global Tier 1 Viral Detection Companies
        3.6.2 List of Global Tier 2 and Tier 3 Viral Detection Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Viral Detection Market Size Markets, 2021 & 2027
        4.1.2 Plaque Assays
        4.1.3 PCR
        4.1.4 ELISA
        4.1.5 Others
    4.2 By Type - Global Viral Detection Revenue & Forecasts
        4.2.1 By Type - Global Viral Detection Revenue, 2016-2021
        4.2.2 By Type - Global Viral Detection Revenue, 2022-2027
        4.2.3 By Type - Global Viral Detection Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Viral Detection Market Size, 2021 & 2027
        5.1.2 Blood & Blood Products
        5.1.3 Cellular & Gene Therapy Products
        5.1.4 Stem Cell Products
        5.1.5 Tissue & Tissue Products
        5.1.6 Vaccines and Therapeutics
    5.2 By Application - Global Viral Detection Revenue & Forecasts
        5.2.1 By Application - Global Viral Detection Revenue, 2016-2021
        5.2.2 By Application - Global Viral Detection Revenue, 2022-2027
        5.2.3 By Application - Global Viral Detection Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Viral Detection Market Size, 2021 & 2027
    6.2 By Region - Global Viral Detection Revenue & Forecasts
        6.2.1 By Region - Global Viral Detection Revenue, 2016-2021
        6.2.2 By Region - Global Viral Detection Revenue, 2022-2027
        6.2.3 By Region - Global Viral Detection Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Viral Detection Revenue, 2016-2027
        6.3.2 US Viral Detection Market Size, 2016-2027
        6.3.3 Canada Viral Detection Market Size, 2016-2027
        6.3.4 Mexico Viral Detection Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Viral Detection Revenue, 2016-2027
        6.4.2 Germany Viral Detection Market Size, 2016-2027
        6.4.3 France Viral Detection Market Size, 2016-2027
        6.4.4 U.K. Viral Detection Market Size, 2016-2027
        6.4.5 Italy Viral Detection Market Size, 2016-2027
        6.4.6 Russia Viral Detection Market Size, 2016-2027
        6.4.7 Nordic Countries Viral Detection Market Size, 2016-2027
        6.4.8 Benelux Viral Detection Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Viral Detection Revenue, 2016-2027
        6.5.2 China Viral Detection Market Size, 2016-2027
        6.5.3 Japan Viral Detection Market Size, 2016-2027
        6.5.4 South Korea Viral Detection Market Size, 2016-2027
        6.5.5 Southeast Asia Viral Detection Market Size, 2016-2027
        6.5.6 India Viral Detection Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Viral Detection Revenue, 2016-2027
        6.6.2 Brazil Viral Detection Market Size, 2016-2027
        6.6.3 Argentina Viral Detection Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Viral Detection Revenue, 2016-2027
        6.7.2 Turkey Viral Detection Market Size, 2016-2027
        6.7.3 Israel Viral Detection Market Size, 2016-2027
        6.7.4 Saudi Arabia Viral Detection Market Size, 2016-2027
        6.7.5 UAE Viral Detection Market Size, 2016-2027
7 Players Profiles
    7.1 Avance Biosciences Inc (US)
        7.1.1 Avance Biosciences Inc (US) Corporate Summary
        7.1.2 Avance Biosciences Inc (US) Business Overview
        7.1.3 Avance Biosciences Inc (US) Viral Detection Major Product Offerings
        7.1.4 Avance Biosciences Inc (US) Viral Detection Revenue in Global (2016-2021)
        7.1.5 Avance Biosciences Inc (US) Key News
    7.2 BSL BIOSERVICE (Germany)
        7.2.1 BSL BIOSERVICE (Germany) Corporate Summary
        7.2.2 BSL BIOSERVICE (Germany) Business Overview
        7.2.3 BSL BIOSERVICE (Germany) Viral Detection Major Product Offerings
        7.2.4 BSL BIOSERVICE (Germany) Viral Detection Revenue in Global (2016-2021)
        7.2.5 BSL BIOSERVICE (Germany) Key News
    7.3 Clean Cells (France)
        7.3.1 Clean Cells (France) Corporate Summary
        7.3.2 Clean Cells (France) Business Overview
        7.3.3 Clean Cells (France) Viral Detection Major Product Offerings
        7.3.4 Clean Cells (France) Viral Detection Revenue in Global (2016-2021)
        7.3.5 Clean Cells (France) Key News
    7.4 Charles River Laboratories International, Inc (US)
        7.4.1 Charles River Laboratories International, Inc (US) Corporate Summary
        7.4.2 Charles River Laboratories International, Inc (US) Business Overview
        7.4.3 Charles River Laboratories International, Inc (US) Viral Detection Major Product Offerings
        7.4.4 Charles River Laboratories International, Inc (US) Viral Detection Revenue in Global (2016-2021)
        7.4.5 Charles River Laboratories International, Inc (US) Key News
    7.5 Lonza Group (Switzerland)
        7.5.1 Lonza Group (Switzerland) Corporate Summary
        7.5.2 Lonza Group (Switzerland) Business Overview
        7.5.3 Lonza Group (Switzerland) Viral Detection Major Product Offerings
        7.5.4 Lonza Group (Switzerland) Viral Detection Revenue in Global (2016-2021)
        7.5.5 Lonza Group (Switzerland) Key News
    7.6 Merck KGaA (Germany)
        7.6.1 Merck KGaA (Germany) Corporate Summary
        7.6.2 Merck KGaA (Germany) Business Overview
        7.6.3 Merck KGaA (Germany) Viral Detection Major Product Offerings
        7.6.4 Merck KGaA (Germany) Viral Detection Revenue in Global (2016-2021)
        7.6.5 Merck KGaA (Germany) Key News
    7.7 Sigma-Aldrich Corporation (US)
        7.7.1 Sigma-Aldrich Corporation (US) Corporate Summary
        7.7.2 Sigma-Aldrich Corporation (US) Business Overview
        7.7.3 Sigma-Aldrich Corporation (US) Viral Detection Major Product Offerings
        7.4.4 Sigma-Aldrich Corporation (US) Viral Detection Revenue in Global (2016-2021)
        7.7.5 Sigma-Aldrich Corporation (US) Key News
    7.8 SGS S.A. (Switzerland)
        7.8.1 SGS S.A. (Switzerland) Corporate Summary
        7.8.2 SGS S.A. (Switzerland) Business Overview
        7.8.3 SGS S.A. (Switzerland) Viral Detection Major Product Offerings
        7.8.4 SGS S.A. (Switzerland) Viral Detection Revenue in Global (2016-2021)
        7.8.5 SGS S.A. (Switzerland) Key News
    7.9 Texcell, Inc. (France)
        7.9.1 Texcell, Inc. (France) Corporate Summary
        7.9.2 Texcell, Inc. (France) Business Overview
        7.9.3 Texcell, Inc. (France) Viral Detection Major Product Offerings
        7.9.4 Texcell, Inc. (France) Viral Detection Revenue in Global (2016-2021)
        7.9.5 Texcell, Inc. (France) Key News
    7.10 WuXi PharmaTech (Cayman) Inc. (China)
        7.10.1 WuXi PharmaTech (Cayman) Inc. (China) Corporate Summary
        7.10.2 WuXi PharmaTech (Cayman) Inc. (China) Business Overview
        7.10.3 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Major Product Offerings
        7.10.4 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Revenue in Global (2016-2021)
        7.10.5 WuXi PharmaTech (Cayman) Inc. (China) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com